BioNJ 2008 Biotechnology Industry Survey : New Jersey Life Sciences...Where Science is Life. New Jersey's biotechnology industry continued to both grow and mature from 2005 to 2007, according to the latest BioNJ industry survey. The industry expanded as measured by several important factors, with the number of public and private companies located in the State increasing beyond 2005 levels, while public companies experienced growth in the number of employees, revenues, research and development expenditures and market cap, according the survey released on June 30, 2008, by BioNJ with assistance from Ernst & Young.

For a copy of the full report, click here.

For a copy of the press release, click here.

BCNJ/Deloitte 2007 Economic Impact Study: New Jersey Biotechnology... A Robust State of Health
A growing base of well-paid jobs, rising spending on goods and services and swelling tax revenues are strong signs that New Jersey's expanding biotechnology industry has made significant and increasing contributions to the State's economy, according to a study released by BCNJ and Deloitte.

For a copy of the full report, click here.

For a copy of the press release, click here.